Subtype
Primary Malignant Liver Neoplasm
CI-CAN-00006507Explore in graph →
807 active trials14 approved drugs17 evidence items
- NCIt
- C34803
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00006507Explore in graph →
Clinical trials
3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (403)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00827723 | Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma | completed | — | 60 | University of Lausanne HospitalsOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT01933945 | Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib(OPTIMIS) | completed | — | 1,676 | BayerINDUSTRY | 31 |
| Nov 6, 2018 |
| clinicaltrials |
| NCT02269995 | Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma | completed | — | 300 | Eisai Co., Ltd.INDUSTRY | 1 | Nov 5, 2018 | clinicaltrials |
| NCT02833298 | Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening | completed | N/A | 25 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT01360255 | AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) | completed | — | 70 | University Hospital FreiburgOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT03698643 | Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization | completed | — | 145 | University Hospital, MontpellierOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT01395030 | PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection | completed | Phase 2 | 64 | Queen's Medical CenterOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT01590732 | Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma | completed | Phase 1 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT01409499 | Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)(2011PTAHCC) | completed | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT00357422 | Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC) | completed | N/A | 36 | Seoul National University HospitalOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT01273766 | Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies | completed | Phase 2 | 16 | Wake Forest University Health SciencesOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT02006030 | Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma(TACE) | completed | Phase 2 | 30 | Polaris GroupINDUSTRY | 1 | Sep 4, 2018 | clinicaltrials |
| NCT01643824 | Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma | completed | N/A | 112 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 23, 2018 | clinicaltrials |
| NCT03636620 | TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial(TACE+RFA) | completed | Phase 3 | 110 | Fudan UniversityOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT00692770 | Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)(STORM) | completed | Phase 3 | 1,114 | BayerINDUSTRY | 28 | Aug 8, 2018 | clinicaltrials |
| NCT02848638 | Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization(PET-Y90) | completed | — | 35 | University of WashingtonOTHER | 0 | Aug 2, 2018 | clinicaltrials |
| NCT01528878 | Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases | completed | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT01502410 | Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 3 | Jun 26, 2018 | clinicaltrials |
| NCT01352728 | Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib | completed | Phase 2 | 50 | Chinese University of Hong KongOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT00906373 | A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver | completed | Phase 2 | 47 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 4, 2018 | clinicaltrials |
| NCT01129193 | AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma | completed | Phase 1 | 44 | Amir MortazaviOTHER | 1 | Jun 4, 2018 | clinicaltrials |
| NCT03534843 | A Comparison Between Child-Pugh and Albumin-Bilirubin Scores | completed | — | 230 | Huazhong University of Science and TechnologyOTHER | 0 | May 29, 2018 | clinicaltrials |
| NCT02021253 | Influence of Probiotics Administration Before Liver Resection in Liver Disease(LIPROCES) | completed | N/A | 64 | University Hospital, RouenOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT03515252 | Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer | completed | Phase 1 | 20 | Ivy Life Sciences, Co., LtdINDUSTRY | 0 | May 9, 2018 | clinicaltrials |
| NCT03516890 | Management of Spontaneous Ruptured Hepatocellular Carcinoma | completed | — | 216 | Huazhong University of Science and TechnologyOTHER | 0 | May 4, 2018 | clinicaltrials |
| NCT02188901 | Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study | completed | N/A | 523 | Yonsei UniversityOTHER | 1 | Apr 26, 2018 | clinicaltrials |
| NCT01665937 | STA-9090 in Patients With Advanced Hepatocellular Cancer | completed | Phase 1 | 16 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01962649 | A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT03349957 | TACE for HCC by TANDEM and Idarubicin(TANDEM-IDA) | completed | — | 98 | University Hospital, MontpellierOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT00101036 | Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 57 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01567709 | Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03490461 | Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation | completed | — | 350 | Yonsei UniversityOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT01829035 | A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC | completed | Phase 3 | 339 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 29, 2018 | clinicaltrials |
| NCT03476421 | R1vascular Hepatectomy for HCC Patients | completed | — | 327 | Humanitas Clinical and Research CenterOTHER | 0 | Mar 26, 2018 | clinicaltrials |
| NCT01490203 | Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma(LiFE) | completed | — | 71 | Seoul National University HospitalOTHER | 1 | Mar 23, 2018 | clinicaltrials |
| NCT03430635 | Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma | completed | — | 40 | Humanitas Clinical and Research CenterOTHER | 0 | Feb 13, 2018 | clinicaltrials |
| NCT02400788 | Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 179 | Yakult Honsha Co., LTDINDUSTRY | 2 | Jan 16, 2018 | clinicaltrials |
| NCT01839630 | Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China(SUCCESS) | completed | — | 302 | BayerINDUSTRY | 1 | Dec 20, 2017 | clinicaltrials |
| NCT03025438 | Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation | completed | — | 13 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03356535 | Metabolic Signature of Healthy Lifestyle and HCC | completed | — | 294 | International Agency for Research on CancerOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT02003339 | Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium(ICY) | completed | N/A | 25 | Center Eugene MarquisOTHER | 1 | Nov 22, 2017 | clinicaltrials |
| NCT00526617 | A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients | completed | Phase 1 | 41 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT00370513 | A Phase I Study of Pazopanib in Adult Patients With Liver Cancer | completed | Phase 1 | 28 | GlaxoSmithKlineINDUSTRY | 3 | Nov 17, 2017 | clinicaltrials |
| NCT01265810 | Caphosol in Oral Mucositis Due to Targeted Therapy(COMTT) | completed | Phase 3 | 64 | Impaqtt FoundationOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT00321594 | Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 54 | National Cancer Institute (NCI)NIH | 2 | Nov 6, 2017 | clinicaltrials |
| NCT01213758 | Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT | completed | — | 14 | University of AarhusOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT01004003 | Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 125 | Boehringer IngelheimINDUSTRY | 8 | Oct 26, 2017 | clinicaltrials |
| NCT03320980 | RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma | completed | — | 30 | Moscow Clinical Scientific CenterOTHER | 0 | Oct 25, 2017 | clinicaltrials |
| NCT00963612 | Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI) | completed | N/A | 80 | University Health Network, TorontoOTHER | 1 | Oct 2, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 13, 2018source: clinicaltrials